Cortexyme

22 Total Employees
Year Founded: 2012

Jobs at Similar Companies

South Bay
Hybrid
San Francisco
Remote
San Francisco
Remote

Similar Companies Hiring

Software • Insurance • Healthtech
San Francisco, CA
85 Employees
Software • Healthtech • Fintech
US
340 Employees
Software • Social Impact • Professional Services • Healthtech • Consumer Web
San Francisco, CA
504 Employees

Cortexyme is developing therapeutics based on data supporting a new theory of the cause of Alzheimer's and other degenerative disorders. Cortexyme is targeting a specific, undisclosed pathogen tied to neurodegeneration and beta amyloid production. The target has been validated in a number of animal models and Cortexyme is currently moving a proprietary small molecule towards human clinical testing.